Startseite Lebenswissenschaften Antiproliferative activity of synthesized some new benzimidazole carboxamidines against MCF-7 breast carcinoma cells
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Antiproliferative activity of synthesized some new benzimidazole carboxamidines against MCF-7 breast carcinoma cells

  • Cigdem Karaaslan , Filiz Bakar und Hakan Goker EMAIL logo
Veröffentlicht/Copyright: 13. September 2017

Abstract

Breast cancer is the most endemic cause of cancer among women in both developed and developing countries. Benzimidazole derivatives exemplify one of the chemical classes that show strong cytotoxic activity especially against breast cancer cells (MCF-7). Aromatic amidine derivatives are known as a group of DNA interactive compounds that bind minor groove of the genome, especially A-T base pairs, and show significant in vitro and in vivo toxicity toward cancer cells. In light of these studies, some new mono/dicationic amidino benzimidazole derivatives were synthesized and evaluated for cytotoxic activity on cultured MCF-7 breast cancer cells. Some of these compounds have strongly inhibited MCF-7 cell viability in a dose-dependent manner compared with clinically used reference compounds, imatinib mesylate and docetaxel. Among them, 4-[(5(6)-bromo-1H-benzimidazole-2-yl)amino]benzene-1-carboxamidine (30) showed the best inhibitory activity with IC50 value of 4.6 nM.

Acknowledgments

The Central Laboratory of Pharmacy Faculty of Ankara University provided support for acquisition of the NMR, mass spectrometer, and elemental analyzer used in this work.

References

1. Payton-Stewart F, Tilghman SL, Williams LG, Winfield LL. Benzimidazoles diminish ERE transcriptional activity and cell growth in breast cancer cells. Biochem Biophys Res Commun 2014;450:1358–62.10.1016/j.bbrc.2014.06.130Suche in Google Scholar PubMed PubMed Central

2. Yoon YK, Ali MA, Wei AC, Shirazi AN, Parang K, Choon TS. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties. Eur J Med Chem 2014;83:448–54.10.1016/j.ejmech.2014.06.060Suche in Google Scholar PubMed

3. Yoon YK, Ali MA, Wei AC, Choon TS, Osman H, Parang K, et al. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities. Bioorg Med Chem 2014;22:703–10.10.1016/j.bmc.2013.12.029Suche in Google Scholar PubMed

4. Li J, Chen X, Ding X, Cheng Y, Zhao B, Lai Z, Hezaimi KA, et al. LATS2 suppresses oncogenic wnt signaling by disrupting b-Catenin/BCL9 interaction. Cell Reports 2013;5:1650–63.10.1016/j.celrep.2013.11.037Suche in Google Scholar PubMed PubMed Central

5. Choi HJ, Fukui M, Zhu BT. Role of cyclin b1/cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole. PLoS One 2011;6:e24312.10.1371/journal.pone.0024312Suche in Google Scholar PubMed PubMed Central

6. Choi HJ, Zhu BT. Role of cyclin b1/cdc2 in mediating bcl-xl phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest. Mol Carcinog 2014;53:125–37.10.1002/mc.21956Suche in Google Scholar PubMed

7. Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, et al. Discovery of the poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem 2009;52: 514–23.10.1021/jm801171jSuche in Google Scholar PubMed

8. Wang J, Ding Q, Fujimori H, Motegi A, Miki Y, Masutani M. Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors. Oncotarget 2016;7: 7701–14.10.18632/oncotarget.6715Suche in Google Scholar PubMed PubMed Central

9. Ratnam K, Low JA. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology. Clin Cancer Res 2007;13:1383–8.10.1158/1078-0432.CCR-06-2260Suche in Google Scholar PubMed

10. Davar D, Beumer JH, Hamieh L, Tawbi H. Role of PARP inhibitors in cancer biology and therapy. Curr Med Chem 2012;19:3907–21.10.2174/092986712802002464Suche in Google Scholar PubMed PubMed Central

11. Livraghi L, Garber JE. PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Med 2015;13:1–16.10.1186/s12916-015-0425-1Suche in Google Scholar PubMed PubMed Central

12. Baraldi PG, Bovero A, Fruttarolo F, Preti D, Tabrizi MA, Pavani MG, et al. DNA minor groove binders as potential antitumor and antimicrobial agents. Med Res Rev 2004;24:475–528.10.1002/med.20000Suche in Google Scholar PubMed

13. Hranjec M, Piantanida I, Kralj M, Suman L, Pavelic K, Karminski-Zamola G. Novel amidino-substituted thienyl- and furylvinylbenzimidazole: derivatives and their photochemical conversion into corresponding diazacyclopenta[c]fluorenes. Synthesis, interactions with DNA and RNA, and antitumor evaluation. J Med Chem 2008;51:4899–910.10.1021/jm8000423Suche in Google Scholar PubMed

14. Starcevic K, Kralj M, Ester K, Sabol I, Grce M, Pavelic K, et al. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles. Bioorg Med Chem 2007;15: 4419–26.10.1016/j.bmc.2007.04.032Suche in Google Scholar PubMed

15. Hranjec M, Starcevic K, Piantanida I, Kralj M, Marjanovic M, Hasani M, et al. Synthesis, antitumor evaluation and DNA binding studies of novel amidino-benzimidazolyl substituted derivatives of furyl-phenyl- and thienyl-phenyl-acrylates, naphthofurans and naphthothiophenes. Eur J Med Chem 2008;43:2877–90.10.1016/j.ejmech.2008.02.010Suche in Google Scholar PubMed

16. Qiu G, Jiang J, Liu XS. Pentamidine sensitizes chronic myelogenous leukemia K562 cells to trail-induced apoptosis. Leuk Res 2012;36:1417–21.10.1016/j.leukres.2012.07.017Suche in Google Scholar PubMed

17. Pathak MK, Dhawan D, Lindner DJ, Borden EC, Farver C, Yi T. Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Mol Cancer Ther 2002;1:1255–64.Suche in Google Scholar PubMed

18. Jung HJ, Suh SI, Suh MH, Baek WK, Park JW. Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells. Cancer Lett 2011;303:39–46.10.1016/j.canlet.2011.01.008Suche in Google Scholar PubMed

19. Karaaslan C, Kaiser M, Brun R, Göker H. Synthesis and potent antiprotozoal activity of mono/di amidino 2-anilinobenzimidazoles versus Plasmodium falciparum and Trypanosoma brucei rhodesiense. Bioorg Med Chem 2016;24:4038–44.10.1016/j.bmc.2016.06.047Suche in Google Scholar PubMed

20. Cee VJ, Downing NS. A one-pot method for the synthesis of 2-amino benzimidazoles and related heterocycles. Tetrahedron Lett 2006;47:3747–50.10.1016/j.tetlet.2006.03.112Suche in Google Scholar

21. Roger R, Neilson DG. The chemistry of imidates. Chem Rev 1961;61:179.10.1021/cr60210a003Suche in Google Scholar

22. Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337–41.10.1016/j.ddtec.2004.11.007Suche in Google Scholar PubMed

23. Petit J, Meurice N, Kaiser C, Maggiora G. Softening the rule of five – where to draw the line? Bioorg Med Chem 2012;20: 5343–51.10.1016/j.bmc.2011.11.064Suche in Google Scholar PubMed

24. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2012;64:4–17.10.1016/j.addr.2012.09.019Suche in Google Scholar

25. Bayomi SM, El-Kashef HA, El-Ashmawy MB, Nasr MN, El-Sherbeny MA, Badria FA, et al. Synthesis and biological evaluation of new curcumin derivatives as antioxidant and antitumor agents. Med Chem Res 2013;22:1147–62.10.1007/s00044-012-0116-9Suche in Google Scholar

26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55.10.1016/0022-1759(83)90303-4Suche in Google Scholar PubMed

27. Kuzma L, Wysokinska H, Rozalski M, Krajewska U, Kisiel W. An unusual taxodione derivative from hairy roots of Salvia austriaca. Fitoterapia 2012;83:770–3.10.1016/j.fitote.2012.03.006Suche in Google Scholar PubMed

28. Starcevic K, Kralj M, Piantanida I, Suman L, Pavelic K, Karminsky-Zamola G. Synthesis, photochemical synthesis, DNA binding and antitummor evaluation of novel cyano- and amidino-substituted derivatives of naphto-furans, naphto-thiophenes, thieno-benzofurans, benzo-dithiophenes and their acyclic precursors. Eur J Med Chem 2006;41:925–39.10.1016/j.ejmech.2006.03.012Suche in Google Scholar PubMed

29. Jarak I, Marjanovic M, Piantanida I, Kralj M, Karminsky-Zamola G. Novel pentamidine derivatives: Synthesis, anti-tumor properties and polynucleotide-binding activities. Eur J Med Chem 2011;46:2807–15.10.1016/j.ejmech.2011.04.001Suche in Google Scholar PubMed

30. Prasanna S, Doerksen RJ. Topological polar surface area: a useful descriptor in 2D-QSAR. Curr Med Chem 2009;16:21–41.10.2174/092986709787002817Suche in Google Scholar PubMed PubMed Central


Supplemental Material:

The online version of this article offers supplementary material (https://doi.org/10.1515/znc-2017-0067).


Received: 2017-4-25
Revised: 2017-7-27
Accepted: 2017-8-20
Published Online: 2017-9-13
Published in Print: 2018-2-23

©2018 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 30.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/znc-2017-0067/html
Button zum nach oben scrollen